Xylem (NYSE:XYL) Stock Price Expected to Rise, UBS Group Analyst Says

Xylem (NYSE:XYL) had its price objective raised by equities research analysts at UBS Group from $168.00 to $175.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the industrial products company’s stock. UBS Group’s target price points to a potential upside of 15.69% from the company’s current price.

Several other research firms also recently commented on XYL. Zacks Research raised Xylem from a “hold” rating to a “strong-buy” rating in a report on Monday, September 22nd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Xylem in a research report on Wednesday, October 8th. Wall Street Zen raised shares of Xylem from a “hold” rating to a “buy” rating in a research report on Saturday, August 9th. Royal Bank Of Canada boosted their price objective on shares of Xylem from $169.00 to $176.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Finally, Mizuho set a $160.00 target price on shares of Xylem in a research note on Wednesday, October 29th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $166.90.

Xylem Price Performance

Shares of NYSE XYL opened at $151.27 on Thursday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.96 and a quick ratio of 1.43. The business has a 50-day moving average of $145.43 and a 200-day moving average of $135.62. The stock has a market capitalization of $36.83 billion, a price-to-earnings ratio of 38.89, a PEG ratio of 2.50 and a beta of 1.15. Xylem has a fifty-two week low of $100.47 and a fifty-two week high of $154.27.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 EPS for the quarter, beating the consensus estimate of $1.23 by $0.14. The firm had revenue of $2.27 billion during the quarter, compared to analysts’ expectations of $2.22 billion. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The business’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.11 earnings per share. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. As a group, sell-side analysts predict that Xylem will post 4.65 earnings per share for the current fiscal year.

Insider Transactions at Xylem

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $139.96, for a total transaction of $139,960.00. Following the completion of the sale, the chief accounting officer directly owned 2,957 shares of the company’s stock, valued at approximately $413,861.72. This trade represents a 25.27% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Victoria D. Harker sold 1,700 shares of the business’s stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total value of $251,838.00. Following the completion of the sale, the director owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This trade represents a 9.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 13,121 shares of company stock worth $1,982,459 over the last quarter. Company insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. State of Wyoming grew its stake in shares of Xylem by 10.4% in the third quarter. State of Wyoming now owns 756 shares of the industrial products company’s stock valued at $112,000 after acquiring an additional 71 shares in the last quarter. Hanson & Doremus Investment Management boosted its holdings in Xylem by 0.9% in the 2nd quarter. Hanson & Doremus Investment Management now owns 8,516 shares of the industrial products company’s stock valued at $1,102,000 after purchasing an additional 77 shares during the period. Princeton Global Asset Management LLC boosted its holdings in Xylem by 2.1% in the 2nd quarter. Princeton Global Asset Management LLC now owns 3,801 shares of the industrial products company’s stock valued at $492,000 after purchasing an additional 79 shares during the period. Private Trust Co. NA grew its position in shares of Xylem by 22.4% during the 3rd quarter. Private Trust Co. NA now owns 459 shares of the industrial products company’s stock worth $68,000 after purchasing an additional 84 shares in the last quarter. Finally, Ascent Wealth Partners LLC increased its holdings in shares of Xylem by 0.6% during the third quarter. Ascent Wealth Partners LLC now owns 14,385 shares of the industrial products company’s stock worth $2,122,000 after purchasing an additional 87 shares during the period. Institutional investors own 87.96% of the company’s stock.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.